Indxx 航天與國防ETF-First Trust MISL 深 滬
等待開盤 04-01 09:30:00 美东时间
44.71
+1.610
+3.74%
華盛通- 最 高44.85
- 今 開43.80
- 成交量 20.29万股
- 最 低 43.5899
- 昨 收 43.10
- 總市值 14.20亿
- 52周最高 51.0714
- 市盈率 靜 --
- 換手率 0.64%
- 52周最低 29.0662
- 委 比 0.00%
- 總股本 3175.00万
- 歷史最高 51.0714
- 量 比 1.11
- 振 幅 2.92%
- 歷史最低 20.0417
- 每 手 1
- 風險率 5.77%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Meta's Oversight Board Calls On Meta To Do More To Allow Users To Identify Such Output
BRIEF-Meta's Oversight Board Calls On Meta To Do More To Allow Users To Identify Such Output March 10 (Reuters) - Oversight Board: META'S OVERSIGHT BOARD-IN ANALYZING SPREAD OF AI-GENERATED CONTENT IN ISRAEL-IRAN WAR, CALLS ON META TO DO MORE TO ALLOW USERS TO IDENTIFY SUCH OUTPUT META'S OVERSIGHT B
03-10 18:04
Shares of defense technology stocks are trading higher following the joint U.S.-Israel attack on Iran over the weekend. Risk of a prolonged conflict provides support for expanded military spending.
Shares of defense technology stocks are trading higher following the joint U.S....
03-02 22:09
BRIEF-Australia's ACCC Says Mobil To Pay A$16 Million In Penalties For Misleading Statements About Fuel Sold
BRIEF-Australia's ACCC Says Mobil To Pay A$16 Million In Penalties For Misleading Statements About Fuel Sold Feb 17 (Reuters) - Australian Competition and Consumer Commission: MOBIL TO PAY A$16M IN PENALTIES FOR MISLEADING STATEMENTS ABOUT FUEL SOLD AT NINE PETROL STATIONS FEDERAL COURT ORDERED MOBI
02-17 10:05
BRIEF-CMS Proposes Regulations To Lower Health Care Costs, Reduce Fraud Practices By Agents & Brokers
BRIEF-CMS Proposes Regulations To Lower Health Care Costs, Reduce Fraud Practices By Agents & Brokers Feb 9 (Reuters) - CMS PROPOSES REGULATIONS TO LOWER HEALTH CARE COSTS, EXPAND CONSUMER CHOICE, AND PROTECT TAXPAYERS CMS: PROPOSED NOTICE OF BENEFIT AND PAYMENT PARAMETERS FOR 2027 WOULD CRACK DOWN
02-10 06:25
BRIEF-Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
BRIEF-Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress Jan 28 (Reuters) - CytoMed Therapeutics Ltd F98.F : CYTOMED THERAPEUTICS- DOES NOT CLAIM THERAPEUTIC CANDIDATES ARE APPROVED FOR COMMERCIAL USE OR CLINICALLY VALIDATED BEYOND CURRENT DEVELOPMENT STAGE CYTOMED THERAP
01-29 00:04
Rocket Lab (RKLB) Stock Is Soaring Friday: What's Driving The Action?
Rocket Lab Corp (NASDAQ: RKLB) rose after Morgan Stanley upgraded the stock to Overweight and raised its price target to $105.
01-17 04:38
L3Harris stock rises on proposed $1B Department of Defense investment
L3Harris Technologies (LHX) shares popped 14% premarket on Tuesday after the defense contractor announced a proposed $1B investment from the Department of War (DoW) to significantly increase capacity ...
01-13 19:14
BRIEF-Warner Bros Discovery Unanimously Recommends Stockholders Reject Paramount Skydance Offer
Dec 17 (Reuters) - Warner Bros Discovery Inc WBD.O: WARNER BROS DISCOVERY: UNANIMOUSLY RECOMMENDS STOCKHOLDERS REJECT PARAMOUNT SKYDANCE OFFER - SEC FILING WARNER BROS DISCOVERY: UNANIMOUSLY RECOMMEND...
2025-12-17 20:03
BRIEF-CompoSecure Says Three Separate Complaints Were Filed By Purported Shareholders Of Co
Dec 12 (Reuters) - CompoSecure Inc CMPO.N: COMPOSECURE: THREE SEPARATE COMPLAINTS WERE FILED BY PURPORTED SHAREHOLDERS OF THE CO FOR NEGLIGENCE & NEGLIGENT MISREPRESENTATION AND CONCEALMENT COMPOSECUR...
2025-12-13 06:46
BRIEF-US FTC Examining Whether TP-Link Misled US Consumers About Its China Split - Bloomberg News
Dec 4 (Reuters) - US FTC EXAMINING WHETHER TP-LINK MISLED US CONSUMERS ABOUT ITS CHINA SPLIT - BLOOMBERG NEWS Source text: https://tinyurl.com/259amyd7 ((Reuters.Briefs@thomsonreuters.com;))
2025-12-05 01:02
